PD-L1 expression levels in mesenchymal stromal cells predict their therapeutic values for autoimmune hepatitis.

Background: Autoimmune hepatitis is a chronic inflammatory hepatic disorder with no effective treatment. Mesenchymal stromal cells (MSCs) have emerged as a promising treatment owing to their unique advantages. However, their heterogeneity is hampering use in clinical applications.